Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Knowing when to start retirement discussions with a financial advisor can enhance your planning. Get the guidance you need to succeed.
20,658 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Institutional investors are pouring money back into XRP ETFs, driving inflows to a five-month high. Analysts say this...
Life360 delivered a strong quarter, but user growth hiccups and a lofty valuation rattled investors. This piece break...
Applied Optoelectronics leads an ongoing optics stock rally, with Lumentum and Coherent gaining as AI data-center spe...
When a mid-cap medical device stock vaults over 5 percent in a single session, investors sit up and take notice. This...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
This article breaks down Westport’s 2026 earnings landscape, translating the Q1 signals into practical moves for read...
Two under-the-radar oil stocks could become big movers. This guide shows how to spot overlooked stocks before they so...
Grayscale Investments and VanEck filed amendments to their spot BNB ETF registrations with the SEC on May 15, 2026, s...
When investors decide to exit Polaris Company, the choice hinges on solid fundamentals and disciplined portfolio math...
Boston travelers gain access to offsite security under the TSA’s straight gate pilot as Delta and JetBlue begin testi...
A sharp weekly drain in Bitcoin ETF products highlights a split in investor demand. While BTC outflows led the pack, ...